Blog post

March 10, 2017

MRI-Ultrasound Fusion Guided Biopsy More Precisely Detects Prostate Cancer

Men who have been diagnosed with prostate cancer have many treatment options. For men who have been diagnosed with low grade, slow growing cancers active surveillance is an option. Active surveillance is the careful monitoring of prostate cancer for signs of progression. If PSA levels rise, or if further biopsies show that the cancer has grown, treatment may be warranted. A recent study found that the criterion for active surveillance needs to be updated to reflect the use of the MRI-Ultrasound (MRI-US) Fusion-Guided Biopsy.

Active surveillance for prostate cancer is being recommended more often today. The eligibility for active surveillance has been based on biopsies performed with transrectal ultrasound (TRUS guided biopsy). These blind, random biopsies have been shown to miss important cancers in the prostate. Targeted MRI-US Fusion-Guided Biopsy is being increasingly utilized.

With the increased use of MRI-US Fusion- Guided Biopsy, fewer patients are considered eligible for active surveillance. The decreased eligibility for active surveillance stems from the MRI-US fusion-guided biopsy’s ability to more precisely detect prostate cancer missed by standard TRUS guided biopsy.

“The only way to definitively diagnose prostate cancer is with a needle biopsy that is submitted to a pathology laboratory for analysis. The use of advanced diagnostics, such as MRI-US Fusion-Guided Biopsy, takes the process several steps further and is crucial when trying to identify and characterize a prostate cancer tumor, assess the risk, and provide a personalized treatment plan for each patient”, says Vituro Health Medical Director Stephen Scionti, M.D.

Research indicates that adding a MRI-US Fusion- Guided biopsy to the standard 12-core biopsy increases the number of patients who would be deemed ineligible for active surveillance. This advanced diagnostic biopsy technique better identifies patients who are eligible or ineligible for active surveillance.

When a prostate cancer requires treatment, there are many options available: surgery, radiation, cryotherapy and HIFU are among them, with HIFU being an excellent alternative to more invasive options. To learn more about Vituro Health’s comprehensive prostate care, call: 866-4VITURO (848876).

Tags: Prostate Cancer Treatment Options and Research News


BACK TO BLOG